128 related articles for article (PubMed ID: 2200902)
1. Role of delayed type hypersensitivity responses in protection during chronic Plasmodium berghei infection as evidenced by homing of radiolabelled bone marrow cells and contact sensitivity.
Wangoo A; Ganguly NK; Mahajan RC
Jpn J Exp Med; 1990 Apr; 60(2):45-50. PubMed ID: 2200902
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity in mice vaccinated against malaria.
Cottrell BJ; Playfair JH; De Souza BJ
Clin Exp Immunol; 1978 Nov; 34(2):147-58. PubMed ID: 310745
[TBL] [Abstract][Full Text] [Related]
3. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
4. Two distinct types of non-specific immunosuppression in murine malaria.
Lelchuk R; Playfair JH
Clin Exp Immunol; 1980 Dec; 42(3):428-35. PubMed ID: 7011609
[TBL] [Abstract][Full Text] [Related]
5. Supplementation of CXCL12 (CXCL12) induces homing of CD11c+ dendritic cells to the spleen and enhances control of Plasmodium berghei malaria in BALB/c mice.
Garnica MR; de Moraes LV; Rizzo LV; de Andrade HF
Immunology; 2005 Jul; 115(3):399-406. PubMed ID: 15946257
[TBL] [Abstract][Full Text] [Related]
6. An in vitro assay for T cell immunity to malaria in mice.
Weinbaum FI; Evans CB; Tigelaar RE
J Immunol; 1976 May; 116(5):1280-3. PubMed ID: 774978
[TBL] [Abstract][Full Text] [Related]
7. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
[TBL] [Abstract][Full Text] [Related]
8. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in murine malaria: suppressor role of macrophages and their products during acute and chronic Plasmodium berghei infection.
Wangoo A; Ganguly NK; Mahajan RC
APMIS; 1990 May; 98(5):407-14. PubMed ID: 2141476
[TBL] [Abstract][Full Text] [Related]
10. Early lymphocyte trapping in malaria infections: a particulate antigen mediated phenomenon.
Lewis-Hughes PH; Howell MJ
J Parasitol; 1984 Jun; 70(3):391-7. PubMed ID: 6387079
[TBL] [Abstract][Full Text] [Related]
11. Stimulation by adjuvants of cell-mediated immune response in Plasmodium berghei infected mice.
Beuria MK; Ravindran B; Das MK
Indian J Biochem Biophys; 1991 Feb; 28(1):68-70. PubMed ID: 2055600
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous increases in immune-competent cells and nitric oxide in the spleen during Plasmodium berghei infection in mice.
Nahrevanian H; Dascombe MJ
J Microbiol Immunol Infect; 2006 Feb; 39(1):11-7. PubMed ID: 16440118
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.
Playfair JH; De Souza JB; Freeman RR; Holder AA
Clin Exp Immunol; 1985 Oct; 62(1):19-23. PubMed ID: 2933196
[TBL] [Abstract][Full Text] [Related]
14. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection.
Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A
Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
Lucas B; Engel A; Camus D; Haque A
Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to chloroquine--sensitive and resistant populations of Plasmodium berghei in mice.
Yadav RN; Kabilan L; Singh MP; Sharma A
J Commun Dis; 1999 Mar; 31(1):9-18. PubMed ID: 10810580
[TBL] [Abstract][Full Text] [Related]
17. Contact and delayed hypersensitivity in the mouse. 3. Depression of contact sensitivity by pre-treatment with antigen and the restoration of immune competence in tolerant mice by normal lymphoid and bone marrow cells.
Asherson GL; Ptak W
Immunology; 1970 Jan; 18(1):99-106. PubMed ID: 4903986
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel antagonist (nifedipine) attenuates Plasmodium berghei-specific T cell immune responses in Balb/C mice.
Moshal KS; Adhikari JS; Bist K; Nair U; Dwarakanath BS; Katyal A; Chandra R
APMIS; 2007 Aug; 115(8):911-20. PubMed ID: 17696947
[TBL] [Abstract][Full Text] [Related]
19. Studies on the induction of tolerance to alloantigens. I. The abrogation of potentials for delayed-type-hypersensitivity response to alloantigens by portal venous inoculation with allogeneic cells.
Qian J; Hashimoto T; Fujiwara H; Hamaoka T
J Immunol; 1985 Jun; 134(6):3656-61. PubMed ID: 2580893
[TBL] [Abstract][Full Text] [Related]
20. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
